<p>From the reviews:</p>
<p></p>
<p>"China, with its potential market of 1.3 billion consumers, has resurrected the western world’s stagnant economic outlook. … This is an interesting book on the global chemical industry and the business practices of multinational companies." (Helmut Hügel, Chemistry in Australia, December, 2005)</p>

“Don’t miss out on China!” and “What are you doing about China?” Catch phrases like these are spreading among managers all over the world. Just take a brief look at the business class occupancy of flights from Europe, North America or Japan to major Chinese cities: This gives you a glimpse of how business people are attracted by steady growth rates of 6 percent to 10 percent. It also indicates how much attention is given to a market featuring 1.3 billion potential consumers and a government committed to rapidly changing the country from an agricultu- dominated developing country into one of the world’s economic powerhouses. Most of the global industrial players have had economic ties with China for decades already, but they were further strengthened after the country’s opening to the world in the early 1980s. Furthermore, China’s accession to the World Trade Or- nization is expected to catapult this already surging economy into another sphere of development.
Les mer
“Don’t miss out on China!” and “What are you doing about China?” Catch phrases like these are spreading among managers all over the world.
The Chemical Industry in China.- The Global Chemical Industry.- The Petrochemical Industry in China.- Activities of European Chemical Companies in China.- Research and Development in China.- Chemical Industry Parks in China.- Trends in the Chinese Fine Chemicals Market — Opportunities and Threats for the European Fine Chemicals Industry.- Chemicals for China's Chip Industry.- The Pharmaceutical Industry in China.- China's Pharmaceutical Market: Business Environment and Market Dynamics.- Developing the Pharmaceutical Business in China — The Case of Novartis.- China's Approach to Innovative Pharmaceutical R&D: A Review.- Foreign Direct Investment by Multinational Corporations in China — The Pharmaceutical Sector.- Competing in the Chinese Antibiotics Market — Cephalosporins 1982–2000.- The Experience of Successful European Companies in China.- Swimming Ahead of the Shoal — The History of BASF in Greater China.- Establishing a Competitive Production Network in Asia.- Bayer — A Multinational Committed to China.- Bicoll — The First Sino-German Biotechnology Company.- Ciba Specialty Chemicals in China — Global Direction and Local Expertise.- Degussa: Transforming the China Region.- A Toolbox for China — Lessons from the China Experience of Degussa Construction Chemicals.- DSM in China: In Touch with Evolving Needs in the Specialty Chemicals Market.- Vitamins — Opportunities and Challenges for Both Western and Chinese Producers.
Les mer
First-hand information about China and strategies of Western companies for market entry and investment With many case examples from Western companies in China Includes supplementary material: sn.pub/extras
Les mer
GPSR Compliance The European Union's (EU) General Product Safety Regulation (GPSR) is a set of rules that requires consumer products to be safe and our obligations to ensure this. If you have any concerns about our products you can contact us on ProductSafety@springernature.com. In case Publisher is established outside the EU, the EU authorized representative is: Springer Nature Customer Service Center GmbH Europaplatz 3 69115 Heidelberg, Germany ProductSafety@springernature.com
Les mer

Produktdetaljer

ISBN
9783540225447
Publisert
2005-06-22
Utgiver
Vendor
Springer-Verlag Berlin and Heidelberg GmbH & Co. K
Høyde
235 mm
Bredde
155 mm
Aldersnivå
Professional/practitioner, P, 06
Språk
Product language
Engelsk
Format
Product format
Innbundet